Hypertension, Neurodegeneration, and Cognitive Decline

Area of Science:

• Neuroscience
• Cardiovascular Science
• Gerontology

Background:

• Elevated blood pressure (hypertension) is a known risk factor for age-related cognitive decline.
• Hypertension disrupts cerebral vasculature integrity, potentially contributing to Alzheimer's disease pathology and cognitive impairment.
• Mechanisms linking vascular damage to neurodegeneration and cognitive deficits require further elucidation.

Purpose of the Study:

• To review current understanding of the relationship between hypertension and cognitive impairment.
• To critically evaluate evidence on hypertension's role in Alzheimer's disease pathobiology.
• To identify knowledge gaps and future research directions in neurovascular dysfunction and neurodegeneration.

Main Methods:

• Review of recent developments in neurovascular biology, brain imaging, and epidemiology.
• Analysis of clinical trials and basic science findings.
• Critical evaluation of existing evidence linking vascular and Alzheimer pathology.

Main Results:

• Growing evidence suggests a link between hypertension and the neurodegenerative pathology of Alzheimer's disease.
• Neurovascular dysfunction plays a critical role in the overlap between vascular pathology and Alzheimer's disease.
• New insights have emerged from clinical and basic research on hypertension's impact on the brain.

Conclusions:

• Understanding the mechanisms by which hypertension exacerbates Alzheimer's pathology is crucial.
• Further research is needed to determine if antihypertensive medications can prevent cognitive impairment.
• Addressing the link between hypertension and cognitive decline is a significant public health challenge.